Search - tctmd.com

Displaying 261 - 280 of 963

Sort: Relevancy | Date

Presentation TCT 2017

Maximizing Long-term Outcome: DES, DCB, and Combination Therapies

Presenter: Mahmood K. Razavi, Peter A. Schneider, George L Adams

October 31, 2017

News Opinion Off Script TCT 2017

Off Script: Monkey See, Monkey . . . Should Really Do, Before Being Set Loose

Kwan S. Lee

October 30, 2017

Presentation TCT 2017

DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB

Presenter: Robert A. Byrne, Ran Kornowski, Juan F. Granada

October 30, 2017

Presentation TCT 2017

Perspectives on the Feasibiity and Trustworthiness of Large, Simple Trials: From TASTE to ADAPTABLE

Presenter: Robert A. Harrington, Sanjay Kaul, Schuyler Jones

October 30, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

$Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy$

Presentation TCT 2017

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Presenter: Robert A. Byrne, Ran Kornowski, Ron Waksman

October 30, 2017

Presentation TCT 2017

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Con!

Presenter: Subhash Banerjee, Robert A. Lookstein

October 30, 2017

Presentation TCT 2017

Risk Score Development, Validation, Precision, Discrimination, and Utility

Presenter: Robert A. Harrington, Sanjay Kaul, Davide Capodanno

October 30, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

Presentation TCT 2017

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Presenter: Robert A. Byrne, Ran Kornowski, Fernando Alfonso

October 30, 2017

Presentation TCT 2017

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Pro!

Presenter: Subhash Banerjee, Bryan T. Fisher

October 30, 2017

Presentation TCT 2017

Is There a Role for Sidebranch Treatment With Drug-Eluting Balloons?

Presenter: Antonio Colombo, Manuel Pan, Jozica Sikic

October 30, 2017

Presentation TCT 2017

Do Patients Really Do Better When Their Cardiologists Are Away at Conferences? Embedding Controls in Observational Studies

Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

Assessment of the Quality and Reliability of Meta-analysis (Summary Level, Network, and Individual Patient Data-Based)

Presenter: Robert A. Harrington, Sanjay Kaul, Giuseppe Biondi-Zoccai

October 30, 2017

Presentation TCT 2017

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

Presenter: Robert A. Byrne, Ran Kornowski, Bruno Scheller

October 30, 2017

Presentation TCT 2017

Natures Randomized Trials: Natural Experiments, Instrumental Variables, and Mendelian Randomization (Strengths and Limitations)

Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh

October 30, 2017

Presentation TCT 2017

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

Presenter: Ioannis Iakovou, Gert Richardt, Shigeru Saito

October 30, 2017

Presentation TCT 2017

The Worst Misinterpretations Ive Seen in Observational Research Studies: How to Spot Them, How to Avoid Them

Presenter: Robert A. Harrington, Sanjay Kaul

October 30, 2017

Presentation TCT 2017

Drug Coated Balloons in Complex SFA Lesions: Case Examples and Data

Presenter: Subhash Banerjee

October 30, 2017

Advertisement

Maximizing Long-term Outcome: DES, DCB, and Combination Therapies

Off Script: Monkey See, Monkey . . . Should Really Do, Before Being Set Loose

DCB Preclinical Perspectives: Mechanisms and Experimental Safety and Efficacy of Older, Current, and Futuristic DCB

Perspectives on the Feasibiity and Trustworthiness of Large, Simple Trials: From TASTE to ADAPTABLE

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Treatment of Refractory In-Stent Restenosis State-of-the-Art Review: From Standard Approaches to Parental Drugs and Vascular Brachytherapy

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Con!

Risk Score Development, Validation, Precision, Discrimination, and Utility

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Treatment of First-time In-Stent Restenosis State-of-the-Art Review: From Lesion Preparation and Imaging to Restenting to DCB

Debate: Drug Coated Balloons Will Eventually Show Benefit for Infrapopliteal Arteries - Pro!

Is There a Role for Sidebranch Treatment With Drug-Eluting Balloons?

Do Patients Really Do Better When Their Cardiologists Are Away at Conferences? Embedding Controls in Observational Studies

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Assessment of the Quality and Reliability of Meta-analysis (Summary Level, Network, and Individual Patient Data-Based)

Drug-Coated Coronary Balloon Therapy: Current State-of-the-Art

Natures Randomized Trials: Natural Experiments, Instrumental Variables, and Mendelian Randomization (Strengths and Limitations)

PLLA-Based Biolimus A9 Elution II: From Nobori to Ultimaster Specifications and Results

The Worst Misinterpretations Ive Seen in Observational Research Studies: How to Spot Them, How to Avoid Them

Drug Coated Balloons in Complex SFA Lesions: Case Examples and Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content